Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

A new quantitative PCR for human parvovirus B19 genotypes.

Toppinen M, Norja P, Aaltonen LM, Wessberg S, Hedman L, Söderlund-Venermo M, Hedman K.

J Virol Methods. 2015 Jun 15;218:40-5. doi: 10.1016/j.jviromet.2015.03.006. Epub 2015 Mar 17.

PMID:
25794796
2.

Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.

Bruhn R, Lelie N, Busch M, Kleinman S; International NAT Study Group..

Transfusion. 2015 Jun;55(6):1195-205. doi: 10.1111/trf.13024. Epub 2015 Feb 27.

PMID:
25727549
3.

Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios.

Bruhn R, Lelie N, Custer B, Busch M, Kleinman S; International NAT Study Group..

Transfusion. 2013 Oct;53(10 Pt 2):2399-412. doi: 10.1111/trf.12299. Epub 2013 Jun 19.

PMID:
23782054
4.

Multicenter evaluation of a commercial multiplex polymerase chain reaction test for screening plasma donations for parvovirus B19 DNA and hepatitis A virus RNA.

Koppelman MH, Cuijpers HT, Wessberg S, Valkeajärvi A, Pichl L, Schottstedt V, Saldanha J.

Transfusion. 2012 Jul;52(7):1498-508. doi: 10.1111/j.1537-2995.2012.03705.x. Epub 2012 May 15.

PMID:
22587637
5.

Screening of blood donors for hepatitis C virus RNA with the MagNA Pure-COBAS AmpliScreen method.

Palomäki P, Wessberg S, Tuomi K, Laitinen H.

Transfusion. 2005 Sep;45(9):1518-22.

PMID:
16131386
6.
7.

Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.

Koistinen V, Wessberg S, Leikola J.

Complement Inflamm. 1989;6(4):270-80.

PMID:
2527715
8.

Supplemental Content

Loading ...
Support Center